The effects of intermittent use of the SGLT-2 inhibitor, dapagliflozin, in overweight patients with type 2 diabetes in Japan: a randomized, crossover, controlled clinical trial.
about
The effects of intermittent use of the SGLT-2 inhibitor, dapagliflozin, in overweight patients with type 2 diabetes in Japan: a randomized, crossover, controlled clinical trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The effects of intermittent us ...... er, controlled clinical trial.
@en
The effects of intermittent us ...... er, controlled clinical trial.
@nl
type
label
The effects of intermittent us ...... er, controlled clinical trial.
@en
The effects of intermittent us ...... er, controlled clinical trial.
@nl
prefLabel
The effects of intermittent us ...... er, controlled clinical trial.
@en
The effects of intermittent us ...... er, controlled clinical trial.
@nl
P2093
P2860
P1476
The effects of intermittent us ...... er, controlled clinical trial.
@en
P2093
Kanako Kato
Kazunori Yanagi
Kunihiro Suzuki
Masaaki Sagara
Sho Wakamatsu
Takafumi Niitani
Yoshimasa Aso
P2860
P304
P356
10.1080/14656566.2017.1317748
P407
P577
2017-04-20T00:00:00Z